Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comprehensive Intestinal Protection Strategy (CIPS) in Laparotomy
NCT03216759Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Aug 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial of dexmedetomidine in Intestinal injury (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoints: Incidence of digestive system complications at 1 week and Concentration of intestinal fatty acid-binding protein at 12 hours. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
Intestinal injury
Beyond the preview
Go deeper on NCT03216759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03216759.